PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $500,996 | -80.7% | 481,727 | -39.0% | 0.00% | -100.0% |
| Q2 2022 | $2,597,000 | +64825.0% | 789,500 | +54198.5% | 0.00% | – |
| Q1 2021 | $4,000 | -82.6% | 1,454 | -82.2% | 0.00% | – |
| Q4 2020 | $23,000 | +360.0% | 8,179 | +256.2% | 0.00% | – |
| Q3 2020 | $5,000 | -54.5% | 2,296 | -41.0% | 0.00% | – |
| Q2 2020 | $11,000 | -45.0% | 3,889 | -31.1% | 0.00% | – |
| Q4 2019 | $20,000 | +25.0% | 5,648 | +24.1% | 0.00% | – |
| Q3 2019 | $16,000 | -11.1% | 4,552 | +15.9% | 0.00% | – |
| Q2 2019 | $18,000 | +800.0% | 3,927 | +435.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 734 | +105.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 358 | -3.0% | 0.00% | – |
| Q2 2018 | $2,000 | -99.2% | 369 | -98.9% | 0.00% | – |
| Q1 2018 | $239,000 | +66.0% | 35,075 | +83.5% | 0.00% | – |
| Q4 2017 | $144,000 | – | 19,118 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |